August 17
12:00 pm - 1:00 pm EDT


How Merck is building biotech labs of the future

Biotech’s lab of the future can’t wait! The potential to actualize a lab of the future is possible today with advances in technology, automation, robotics, and digitalization. These advances are reshaping how scientists run R&D labs, conduct experiments, share data and make decisions. However, legacy infrastructure and disconnected solutions are creating barriers that prevent achieving the promise of a lab of the future.

Lab of the future requires a modern, connected, adaptable solution that manages work traditionally done in siloed – and now outdated – ELN and LIMS solutions. With a shared solution connecting R&D data, teams can manage samples and processes with seamless handoffs and complete traceability. Join us for an engaging discussion with Dan Chapman, Director of the Experiment Design and Execution Platform Product at Merck, and experts from Zifo and Benchling.

In this webinar, we’ll discuss:
  • The challenges with legacy systems for today’s advanced biomolecules
  • Advantages of a modern LIMS
  • How to choose the right modern LIMS
  • Strategies to drive effective change management and adoption

register now
register for the webinar

No cost to register, subject to confirmation

By registering for this event, you accept that you may receive direct communication from the sponsor(s).

If you are experiencing problems with your registration, please try the Zoom registration page.

Dan Chapman

Dan Chapman

Director, Product Line Leader, Merck

Dan Chapman is a software product manager and product line leader within Merck IT based in the Boston, MA area. He currently leads an internally facing product team providing products to support research and development scientists.

Prior to this, he has spent time on the vendor side working with data management and analytics products and time at the lab bench in late-stage development. He was drawn to the intersection of software and science as an Analytical Chemist in the early 2000s and didn’t look back. Dan has a bachelor’s degree in chemistry and a master’s degree in International Business Management, both from the University of Newcastle-upon-Tyne in the UK, and has over 20 years’ experience in and around the pharmaceutical industry.

Dinesh Agaram

Dinesh Agaram

Consultant Development, Zifo

Dinesh started his career as an Innovation Lead in Bioinformatics with IBM Software Labs, following which he gained over two decades of experience in Life Sciences Digital Transformation Consulting and Change Leadership. Through this time, Dinesh has led and supported a variety of strategic initiatives in reputable organizations in the Life Sciences (Syngenta, AstraZeneca, Pfizer) and in consultancies (Cognizant, Thomson-Reuters), and has set up Data and IT teams in start-ups.

Starting recently with Zifo, Dinesh leads Consulting Practice development in Europe and is involved in pre-sales and delivery activities across the company’s client base in scientific industries.

His professional interests include reimagining the future of Automation and Data in their application to Scientific R&D, and championing robust change management principles in strategic transformation programs.

Dinesh has obtained a master’s degree in computer science from Anna University and an MBA from Cranfield.

Casey Kraft

Casey Kraft

Regional Lead, Professional Services, Benchling

Casey currently leads the east coast Professional Services team at Benchling. During her time here, Casey has run implementations for clients of all shapes and sizes, from very early startups to global enterprises.

Casey has a Ph.D. in pharmacology from the University of Pittsburgh, but after completing her post-doctoral work, she realized she liked helping other people do science even more than she enjoyed doing it herself. Since that epiphany, she has amassed more than 13 years of experience working in post-sales customer support roles, and is very passionate about making her clients successful in their science.

Arsalan Arif

Arsalan Arif

Founder & publisher, endpoints news

Arsalan Arif is a news media entrepreneur who set out in 2015 to build his vision of an independent biotech news company at Endpoints News.